Mini Quiz: Schizophrenia Research

Poll

Current trials are investigating adjunctive monoclonal antibody immunotherapy in schizophrenia. Take the quiz and learn more.

Current trials are investigating adjunctive monoclonal antibody immunotherapy in schizophrenia with all of the following agents EXCEPT:

A. Adalimumab
B. Canakinumab
C. Siltuximab
D. Tocilizumab
E. Natalizumab
Related Videos
nicotine use
brain schizophrenia
schizophrenia
schizophrenia
exciting, brain
Related Content
Here are highlights from the week in Psychiatric Times.

The Week in Review: April 15-19

April 20th 2024
Article
Treating ‘Morally Objectionable’ Patients

Treating ‘Morally Objectionable’ Patients

September 27th 2021
Podcast
Researchers investigated the effects of this supplementation on cognitive function and disease severity in schizophrenia. Here’s what they found.

Study Finds That Probiotics, Vitamin D May Enhance Cognitive Function in Schizophrenia

April 12th 2024
Article
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021
Podcast
What is new in research on schizophrenia?

Schizophrenia Research Roundup: April 12, 2024

April 12th 2024
Article
Here are some updates from the world of psychiatry throughout the month of March.

Psychiatry in the News: March 2024

March 29th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.